ONE游戏官网

Director Su Cheng of the Wuhan Donghu High-tech Zone Committee's Greater Bay Area Office Visits Shenzhen Cell Valley for Exchange

Date:09-13  Hits:  Belong to:News

图片

On September 10, Su Cheng, Director of the Industrial Cooperation Office in the Greater Bay Area under the Management Committee of Wuhan Donghu High-tech Development Zone (also known as "Optics Valley"), along with staff member Wan Qian, visited Shenzhen Cell Valley for exchange and discussion. Our Chief Scientist, Professor Wang Jianxun; Head of Marketing, Sun Rui; and Director of the General Administration Office, Wang Lu, extended a warm welcome to the delegation.

图片

Under the introduction of Director Wang Lu, Director Su and his delegation gained an initial understanding of Shenzhen Cell Valley's strategic layout, founding team, development history, corporate honors, core technologies, and team structure. They also developed a further appreciation of Shenzhen Cell Valley's one-stop, full-process services spanning from basic research to clinical translation.

图片

During the symposium, Professor Wang Jianxun noted that Shenzhen Cell Valley's core technology team has successfully utilized self-produced industrial-grade retroviral vectors to prepare CAR-T cell products targeting over 50 targets. These products have demonstrated excellent safety and efficacy in clinical research at multiple domestic medical institutions. In addition, Shenzhen Cell Valley has successfully established multiple subsidiaries in Beijing, the Greater Bay Area, and the Hong Kong Special Administrative Region, and has set up cell preparation centers in Yunnan and Henan. Looking ahead, the company's strategic development plan will cover markets from Southeast Asia to broader international regions, committed to providing high-quality, affordable cell therapy products, and truly realizing the corporate vision of "Cells benefit all, genes create the future."

Director Su introduced that the total area of the Optics Valley region has expanded to 518 square kilometers. In terms of human resources, the region is home to numerous institutions of higher learning; it also hosts 71 national-level research institutes, including the Wuhan Branch of the Chinese Academy of Sciences. In addition, Optics Valley has established eight specialized industrial parks, among which the Optics Valley Biocity has grown into the most influential, innovative, and comprehensive industrial cluster in the central region's biopharmaceutical sector. This industrial cluster has played an active role in radiating and driving the coordinated development of the province's "1+9" regional bio-industrial parks, and has become a key driver of high-quality regional economic development. The purpose of this visit was to conduct on-site research and engage in more in-depth communication with Shenzhen Cell Valley, with the expectation of promoting further development in the cell therapy field between Central China and the Greater Bay Area.

This visit enhanced mutual understanding between the two parties. Both sides expressed the hope to engage in broader cooperation in the future, jointly promoting the development of the cell therapy industry in Central China, the Greater Bay Area, and across China.


图片

About Wuhan Donghu High-tech Development Zone

Wuhan Donghu High-tech Development Zone, abbreviated as Donghu High-tech Zone and also known as "China Optics Valley" or simply "Optics Valley," was established in 1988. It is one of China's first national-level high-tech zones, the second national independent innovation demonstration zone, and the Wuhan section of the China (Hubei) Pilot Free Trade Zone. It has also been approved as the National Optoelectronic Information Industry Base, the National Bio-industry Base, a talent base for centrally administered state-owned enterprises, and one of the first national demonstration bases for innovation and entrepreneurship. After more than 30 years of development, the comprehensive strength and brand influence of Donghu High-tech Zone have significantly improved. Its knowledge creation and technological innovation capabilities have risen to first place among 169 national-level high-tech zones nationwide, making it one of the ten key "world-class high-tech parks" in China.

The total planned area of Donghu High-tech Zone is 518 square kilometers, housing 42 institutions of higher learning including Wuhan University and Huazhong University of Science and Technology, 56 national and provincial-level research institutes, over 300,000 professional technical personnel, and more than 800,000 university students, making it one of China's three major intelligence-intensive regions.


About Us
Scan to follow our latest newsScan to follow our latest news
Contact Us
400-800-1266

Working hours: Monday to Friday, 9:00-18:00

Contact:Ms. Lai

Email:laijiaqi@loteriass.com

Address:No. 1, Rongtian Road, Jinsha Community, Kengzi Street, Pingshan District, Shenzhen, China (Hepure Biomedical Ecological Park)

Shenzhen Cell Valley Biopharmaceutical Co., Ltd. is a leading one-stop comprehensive outsourcing service provider for China’s cell and gene therapy industry. It is also among the first domestic CRO/CDMO enterprises to hold GMP-compliant industrial production capabilities for clinical-grade retroviral vectors. As a key project for the construction of Shenzhen’s public technical service platform for CRO/CDMO, the company has been listed in the city’s newly announced "20+8" strategic emerging industries initiative.
Shenzhen Cell Valley is equipped with the capacity to conduct standardized and industrialized production of GMP-grade cellular products including CAR-T cells. Its core production lines cover a full spectrum of cellular products such as CAR-T, CAR-NK, CAR-M, γδT, TIL and TCR-T. In addition, the company runs production lines for a diverse range of viral vectors (including RVV, LVV and AAV) and non-viral vectors, as well as for cellular raw materials for therapeutic development—such as exosomes, genetically engineered antibodies, cytokines, oncolytic viruses and vaccines.
 Copyright 粤ICP备2024168379号 互联网药品信息服务资格证书:(粤)-非经营性-2022-0426  Technical Support:YouDian Software